National and International Guidelines for COPD

National Institutes of Health. Global strategy for asthma management and prevention: National Heart, Lung, and Blood Institute/World Health Organization workshop report. 1995 Barnes, 2000, Mechanisms in COPD: differences from asthma, Chest, 117, 10S, 10.1378/chest.117.2_suppl.10S Celli, 2000, The importance of spirometry in COPD and asthma: effect on approach to management, Chest, 117, 15S, 10.1378/chest.117.2_suppl.15S Jorenby, 1999, A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation, N Engl J Med, 340, 685, 10.1056/NEJM199903043400903 Anthonisen, 1994, Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1: The Lung Health Study, JAMA, 272, 1497, 10.1001/jama.1994.03520190043033 Pauwels, 1999, Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking, N Engl J Med, 340, 1948, 10.1056/NEJM199906243402503 Calverley, 1999, Effect of three years treatment with fluticasone propionate in patients with moderately-severe COPD [abstract], Am J Respir Crit Care Med, 159, A524